Literature DB >> 11602079

An evidence-based approach to diagnosing renovascular hypertension.

M J Bloch1.   

Abstract

Making the diagnosis of potentially reversible renovascular hypertension can be problematic. Although there are a number of noninvasive screening tests available, no one study is appropriate for every patient. In general, the available tests can be divided into those that identify the functional consequences of a renal artery obstruction (angiotensin-converting enzyme inhibitor-augmented renography) and those that identify the anatomic presence of stenosis (duplex ultrasonography, magnetic resonance angiography, and contrast tomography angiography). The most appropriate diagnostic approach is based largely on the clinical index of suspicion, the potential etiology of the renal artery lesion (fibromuscular dysplasia or atherosclerosis), and the individual patient's physiology and presentation. A potential treatment algorithm is presented.

Entities:  

Mesh:

Year:  2001        PMID: 11602079     DOI: 10.1007/s11886-001-0070-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  43 in total

1.  Contrast-enhanced, K-space-centered, breath-hold MR angiography of the renal arteries and the abdominal aorta.

Authors:  J C Steffens; J Link; J Grässner; S Mueller-Huelsbeck; G Brinkmann; M Reuter; M Heller
Journal:  J Magn Reson Imaging       Date:  1997 Jul-Aug       Impact factor: 4.813

2.  The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience.

Authors:  B C van Jaarsveld; P Krijnen; F H Derkx; H Y Oei; C T Postma; M A Schalekamp
Journal:  Arch Intern Med       Date:  1997-06-09

3.  Renal duplex sonography: evaluation of clinical utility.

Authors:  K J Hansen; R W Tribble; S W Reavis; V J Canzanello; T E Craven; G W Plonk; R H Dean
Journal:  J Vasc Surg       Date:  1990-09       Impact factor: 4.268

4.  Evaluation of duplex ultrasound and captopril renography for detection of renovascular hypertension.

Authors:  M Johansson; G Jensen; M Aurell; P Friberg; H Herlitz; H Klingenstierna; R Volkmann
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

5.  Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.

Authors:  J Radermacher; A Chavan; J Bleck; A Vitzthum; B Stoess; M J Gebel; M Galanski; K M Koch; H Haller
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

6.  Splint renal function after captopril in unilateral renal artery stenosis.

Authors:  G J Wenting; H L Tan-Tjiong; F H Derkx; J H de Bruyn; A J Man in't Veld; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

7.  Magnetic resonance angiography of renal artery stenosis.

Authors:  W M Gedroyc; P Neerhut; R Negus; A Palmer; A al Kutoubi; D Taube; B Hulme
Journal:  Clin Radiol       Date:  1995-07       Impact factor: 2.350

8.  A clinical prediction rule for renal artery stenosis.

Authors:  P Krijnen; B C van Jaarsveld; E W Steyerberg; A J Man in 't Veld; M A Schalekamp; J D Habbema
Journal:  Ann Intern Med       Date:  1998-11-01       Impact factor: 25.391

9.  The captopril test for identifying renovascular disease in hypertensive patients.

Authors:  F B Muller; J E Sealey; D B Case; S A Atlas; T G Pickering; M S Pecker; J J Preibisz; J H Laragh
Journal:  Am J Med       Date:  1986-04       Impact factor: 4.965

10.  Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Multicentre Study Group.

Authors:  E Fommei; S Ghione; A J Hilson; L Mezzasalma; H Y Oei; A Piepsz; D Volterrani
Journal:  Eur J Nucl Med       Date:  1993-07
View more
  1 in total

1.  The contrast-enhanced Doppler ultrasound with perfluorocarbon exposed sonicated albumin does not improve the diagnosis of renal artery stenosis compared with angiography.

Authors:  Odila U N Teixeira; Luiz A Bortolotto; Hélio Bernardes Silva
Journal:  J Negat Results Biomed       Date:  2004-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.